Treatment Pathway

Treatment of Liver Cancer (Hepatocellular Carcinoma)

Hepatocellular carcinoma typically develops in the setting of chronic liver disease or cirrhosis due to hepatitis B, hepatitis C, or alcohol. It is a leading cause of cancer death globally.

ACG (American College of Gastroenterology)BSG (British Society of Gastroenterology)ESGEAASLD (liver)ECCO (IBD)Maastricht Consensus (H. pylori)NICE

Symptoms Causes Treatment When to See a Doctor Related Questions

Managing Liver Cancer (Hepatocellular Carcinoma) effectively requires a combination of medical treatment, lifestyle modification, and regular monitoring. With a structured management plan, most people with Liver Cancer (Hepatocellular Carcinoma) can maintain a good quality of life and prevent serious complications.

First-Line Treatment Principles

✓PPI as cornerstone for acid-related disorders (GERD, peptic ulcer, H. pylori eradication regimens)
✓H. pylori eradication: PPI + clarithromycin + amoxicillin (7–14 days); bismuth quadruple if resistance suspected
✓IBD: 5-ASA for mild UC; corticosteroids for induction; biologics (anti-TNF, anti-integrin) for moderate-severe
✓Hepatitis B/C: antiviral therapy (tenofovir/entecavir for HBV; DAAs for HCV with >95% SVR rate)
✓Cirrhosis: treat underlying cause + complications (ascites, varices, HE) systematically

What to Do Now

Learn your personal risk factors for Liver Cancer (Hepatocellular Carcinoma) (family history, age, lifestyle)
Attend regular health check-ups and screening tests appropriate for your age and risk
Track new or changing symptoms, especially those associated with Liver Cancer (Hepatocellular Carcinoma)
Use our AI symptom checker to assess whether your symptoms fit an early Liver Cancer (Hepatocellular Carcinoma) pattern
Discuss preventive strategies and early monitoring with your GP
Build a personalised management plan with your GP or specialist
Adhere consistently to prescribed medications — do not stop without medical advice
Adopt a Liver Cancer (Hepatocellular Carcinoma)-appropriate diet (anti-inflammatory, low-glycaemic, or disease-specific)

Non-Pharmacological Management

•Dietary modification: low-FODMAP for IBS; gluten-free diet for coeliac disease; low-fat for pancreatitis
•Alcohol cessation: critical in alcoholic liver disease, pancreatitis, GERD
•Weight loss: reduces GERD symptoms and improves NAFLD (5–10% weight loss reduces hepatic steatosis)
•Elevate bed head; avoid late meals; avoid trigger foods in GERD
•Regular meals; avoid NSAIDs and aspirin (gastric mucosal damage); no smoking
•Endoscopic surveillance: Barrett's oesophagus, IBD colon cancer screening, cirrhosis for HCC
•Vaccination: hepatitis A and B for unvaccinated at-risk patients

Treatment Goals

🎯Symptom remission and maintained quality of life in IBD/IBS/GERD

🎯Mucosal healing in IBD (endoscopic remission)

🎯H. pylori eradication confirmed

🎯Prevention of cirrhosis complications: hepatic decompensation, variceal bleeding, HCC

🎯Sustained virological response (SVR) in hepatitis C

Monitoring Parameters

◆LFTs, bilirubin, albumin, INR: liver function — monthly in acute liver disease, every 3–6 months in chronic
◆FBC: anaemia (GI bleeding, malabsorption), leucopenia (azathioprine toxicity)
◆Faecal calprotectin: non-invasive IBD disease activity monitoring
◆Colonoscopy: IBD dysplasia surveillance every 1–5 years depending on duration and extent
◆H. pylori test of cure: UBT or stool antigen 4 weeks after eradication therapy
◆Hepatic elastography (FibroScan): assess fibrosis progression in chronic liver disease
◆Alpha-fetoprotein + ultrasound: HCC surveillance in cirrhosis every 6 months

Red Flags — When to Escalate

⚠Any of the characteristic symptoms of Liver Cancer (Hepatocellular Carcinoma) — even mild — in a high-risk individual
⚠Progressive worsening of early warning signs over weeks
⚠Laboratory abnormalities (e.g., blood sugar, inflammatory markers) without full symptoms
⚠Unexplained weight loss, night sweats, or fatigue persisting >2 weeks
⚠Strong family history of Liver Cancer (Hepatocellular Carcinoma) combined with new relevant symptoms
⚠Sudden worsening of Liver Cancer (Hepatocellular Carcinoma) symptoms despite established treatment

Escalation Criteria

→Acute GI bleeding: upper GI endoscopy within 24h; resuscitation, IV PPI, haemostatic therapy
→Acute severe UC (Truelove-Witts criteria) → hospitalisation, IV steroids; escalate to biologics/surgery if no response at 72h
→Hepatic encephalopathy: lactulose, rifaximin; identify precipitant; assess for transplant listing
→Acute-on-chronic liver failure: specialist gastroenterology/transplant centre referral

Special Populations

Pregnancy: many IBD biologics continue through pregnancy (anti-TNF switch to certolizumab if needed); avoid methotrexate

Elderly: NSAIDs major GI risk — prescribe PPI; vigilance for GI bleeding on anticoagulants

Paediatric IBD: growth and development monitoring; early biological therapy consideration

Immunocompromised: lower threshold for investigation; atypical pathogens (CMV colitis, Cryptosporidium)

Clinical Insights

Differential Diagnosis

Conditions that mimic Liver Cancer (Hepatocellular Carcinoma) — key distinguishing features & tests

Not sure about your symptoms?

Our AI Symptom Checker analyses your symptoms and suggests the most likely diagnoses — including relevant treatment pathways.

Use AI Symptom Checker →